Entering text into the input field will update the search result below

Enteris highlights practices for content uniformity in solid oral dosage manufacturing

Mar. 07, 2022 1:17 PM ETSWK Holdings Corporation (SWKH)By: Ravikash, SA News Editor

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples

gorodenkoff/iStock via Getty Images

  • Enteris BioPharma, a unit of SWK Holdings (NASDAQ:SWKH), announced the publication of a new white paper titled 'HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity.'
  • The paper, co-authored by Thomas Daggs, vice president of

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About SWKH

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SWK Holdings Corporation
Acacia Research Corporation
FlexShopper, Inc.
LM Funding America, Inc.
A-Mark Precious Metals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.